Tuesday, July 14, 2026

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Kim Yo Jong Rebukes South Korea, Calls U.S.-ROK Military Cooperation a Threat Before Washington Summit

Kim Yo Jong criticizes South Korea's appeasement towards North Korea, aiming to create discord with the U.S. ahead of their summit.

Tag: 64 teams

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.